Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.

Jagpreet ChhatwalSumeyye SamurBrian KuesTurgay AyerLewis Rowland RobertsFasiha KanwalChin HurDrew Michael S DonnellRaymond T Chung

Published in: Hepatology (Baltimore, Md.) (2017)

Our findings suggest that the optimal MELD threshold below which decompensated cirrhosis patients should receive HCV treatment while awaiting LT is between 23 and 27, depending on the UNOS region. (Hepatology 2017;65:777-788).

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
hepatitis c virus
patient reported outcomes
replacement therapy